atrial fibrillation
Prevention of Ischemic Stroke among Older Adults: Primary and Secondary
Prevention of Ischemic Stroke among Older Adults: Primary and Secondary
Warfarin Anticoagulation in Older Adults: A Review of Outpatient Initiation and Monitoring
Warfarin Anticoagulation in Older Adults: A Review of Outpatient Initiation and Monitoring
Atrial Fibrillation: Rate vs. Rhythm Control and Anticoagulation
Atrial Fibrillation: Rate vs. Rhythm Control and Anticoagulation
Atrial Fibrillation: Etiology, Diagnosis, and Inital Workup
Atrial Fibrillation: Etiology, Diagnosis, and Inital Workup
Is ASA as Good as Warfarin in the Treatment of Atrial Fibrillation?
Is ASA as Good as Warfarin in the Treatment of Atrial Fibrillation?
Findings of a Provocative New Meta-Analysis
Jason M. Burstein, MD
Internal Medicine Resident,
University of Toronto,
Toronto, ON.
Shabbir M.H. Alibhai, MD, MSc, FRCP(C)
Clinical Assistant, Internal
Medicine & Geriatrics,
University Health Network, Toronto, ON.
Amiodarone: The Pharmacological Management of Atrial Fibrillation
Amiodarone: The Pharmacological Management of Atrial Fibrillation
Rubina Sunderji, Pharm.D., FCSHP
Pharmacotherapeutic Specialist&emdash;Cardiology,
Pharmaceutical Sciences CSU,
Vancouver General Hospital,
Clinical Assistant Professor,
Faculty of Pharmaceutical Sciences,
University of British Columbia,
Vancouver, BC.
Cardioversion to “Kick-start” a Heart to Normal Sinus Rhythm
Cardioversion to “Kick-start” a Heart to Normal Sinus Rhythm
D'Arcy Little, MD, CCFP
Director of Medical Education,
York Community Services, Toronto, ON.
Informed Patient Participation in Decision-Making Leads to Better Results in the Management of Atrial Fibrillation
Informed Patient Participation in Decision-Making Leads to Better Results in the Management of Atrial Fibrillation
Christopher B. Overgaard, MSc, MD
Diltiazem, Verapamil and Beta-blockers for Rate control in Atrial Fibrillation
Diltiazem, Verapamil and Beta-blockers for Rate control in Atrial Fibrillation
Andrea Sotirakopoulos, BSc